Watch this company for free updates
Simply enter your email address below and we will send you an email when the company files any documents or there is a change to their credit report.
We require your email address in order to send you alerts by email. You can unsubscribe at any time.
Thank you, you are now watching this company.
You will receive email updates when this company's information changes.
You can choose which alerts you receive and can unsubscribe at any time.
Unlock BIODEXA PHARMACEUTICALS (WALES) LIMITED's Credit Report?
Unlock The Full Report
- Credit score, financials and risk data
- Directors, shareholders and ownership
- CCJs, payment behaviour and filing history
- 5 official Companies House documents
- Instant download and online viewing
- Email alerts for key changes
- Personal monitoring dashboard
Upgrade to Lite
- 5 credit reports
- 100 accounts downloads
- 100 accounts exports
Your plan will start immediately and the time remaining on your existing plan will be refunded
Yes, upgrade to LiteBIODEXA PHARMACEUTICALS (WALES) LIMITED
1 CASPIAN POINT CASPIAN WAY, CARDIFF, CF10 4DQ
Buy Report - £20
Download PDF
Unlock the Full Company Report
- ✓ Check whether this company is legitimate
- ✓ See if this company is likely to run into financial trouble
- ✓ Find out who owns and runs the company
- ✓ Avoid risky business relationships
- ✓ Get instant updates if anything important changes
- ✓ Access official company documents for free
BIODEXA PHARMACEUTICALS (WALES) LIMITED
Private limited with Share Capital
Active - Accounts Filed
10 October 2003
72110 Research and experimental development on biotechnology - Research and experimental development on biotechnology
Available to 17 Apr 2026. Next accounts due by 30 Sep 2027
Is BIODEXA PHARMACEUTICALS (WALES) LIMITED in debt to you?
Don't write it off. As exclusively featured on Can't Pay? We'll Take It Away!, DCBL provides a nationwide service recovering over £85 million annually.
Our unique "One Solution" works seamlessly with DCB Legal, managing debt recovery from the first letter through to High Court enforcement.
We act fast to protect your cash flow and recover what you're owed. Recover your debt with the UK's experts.
Current Directors & Secretaries
For a full in-depth analysis on each of these directors, click any of the links below
| Name | Role | Date Of Birth | Appointed |
|---|---|---|---|
| Mrs Fiona Mary Powell | Director | ||
| Mr Stephen Anthony Stamp | Director | ||
| Mr Stephen Stamp | Company Secretary |
Previous Directors & Secretaries
Mortgages and Charges
Total Outstanding
0
Total Satisfied
8
| Type | Created | Registered | Persons Entitled | Status |
|---|---|---|---|---|
| Midcap Financial Trust As Agent For The Lenders. | SATISFIED | |||
| Midcap Financial Trust As Security Agent And Trustee For The Beneficiaries. | SATISFIED | |||
| Silicon Valley Bank | SATISFIED | |||
| Debenture | Sustainable Technology Partnership Lp As Security Trustee | SATISFIED | ||
| Debenture | Sustainable Technology Partnership Lp (As Security Trustee) | SATISFIED | ||
| Debenture | Hsbc Bank PLC | SATISFIED | ||
| Debenture | Sustainable Technology Partnership Lp (As Security Trustee) | SATISFIED | ||
| Debenture | Hsbc Bank PLC | SATISFIED |
Key Financials
| Accounts | |||||
|---|---|---|---|---|---|
| Cash | £28,000.00 | £8,000.00 | £306,000.00 | £33,000.00 | £526,000.00 |
| Net Worth | -£3,448,000.00 | -£2,636,000.00 | -£2,168,000.00 | -£1,292,000.00 | £920,000.00 |
| Total Current Liabilities | £3,631,000.00 | £2,983,000.00 | £2,617,000.00 | £2,167,000.00 | £479,000.00 |
| Total Current Assets | £95,000.00 | £157,000.00 | £546,000.00 | £1,037,000.00 | £1,041,000.00 |
Frequently Asked Questions about BIODEXA PHARMACEUTICALS (WALES) LIMITED
Detailed answers about BIODEXA PHARMACEUTICALS (WALES) LIMITED, including incorporation, status, business activity, and accounts information.
When was BIODEXA PHARMACEUTICALS (WALES) LIMITED founded?
BIODEXA PHARMACEUTICALS (WALES) LIMITED was officially incorporated on 10 October 2003 and is registered under company number 04929486. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is BIODEXA PHARMACEUTICALS (WALES) LIMITED?
Private limited with Share Capital. This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations. For example, a private limited company (Ltd) limits the personal liability of its shareholders.
What is the current status of BIODEXA PHARMACEUTICALS (WALES) LIMITED?
BIODEXA PHARMACEUTICALS (WALES) LIMITED's current status is Active. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does BIODEXA PHARMACEUTICALS (WALES) LIMITED do?
BIODEXA PHARMACEUTICALS (WALES) LIMITED operates in the following sector: 72110 Research and experimental development on biotechnology - Research and experimental development on biotechnology . This provides insight into the company’s primary business activities and industry focus. Knowing the SIC code and description is useful for market research, assessing competitors, and understanding potential business risks.
What is BIODEXA PHARMACEUTICALS (WALES) LIMITED's registered address?
The registered office address of BIODEXA PHARMACEUTICALS (WALES) LIMITED is Caspian Way, Cardiff, Cardiff, CF10 4DQ. This is the official address filed with Companies House for legal and statutory correspondence.
Is BIODEXA PHARMACEUTICALS (WALES) LIMITED financially stable?
Based on the latest accounts up to 17 Apr 2026, BIODEXA PHARMACEUTICALS (WALES) LIMITED has filed financial statements showing its assets, liabilities, and overall trading performance. The next accounts are due by 30 Sep 2027. Reviewing these accounts helps assess the company’s financial stability, creditworthiness, and risk profile, which is crucial for investors, suppliers, and potential business partners.